Kantonsspital St.Gallen

PROMET-Multicenter, Randomized Phase II Trial of Salvage Radiotherapy +/- Metformin for Patients with Prostate Cancer after Prostatectomy

abstract To determine if SRT plus Metformin is suerior to SRT alone in the ndpont of time to Progression after prostatectomy failure.
Target: 170 patients
type of project clinical studies
status ongoing - recruiting phase
start of project 2017
end of project 2029
study design Multicenter, Randomized Phase II
responsible person Dr. Paul Martin Putora